Characteristics of the 9 patients who experienced a CVD
| Event . | Time, wk . | Age, y . | Factor level, % . | QRISK, % . | Smoking . | CVD in family (aged <60 y) . | DM . | HCV . | HIV . | BMI, kg/m2 . | BP, mm Hg . | aHT . | Cholesterol ratio . | Creatinine, μmol/L . |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stroke | 98 | 77 | <1 | 10.8 | No | No | No | Spontaneous clearance | Yes | 17.7 | 146/86 | No | 3.36 | 62 |
| IHD | 49 | 47 | <1 | 6.3 | No | Yes (no) | Yes | Treated | Yes | 23.0 | 120/90 | Yes | 5.00 | 202 |
| Stroke | 188 | 58 | <1 | 13.8 | No | Yes (yes) | No | Negative | No | 25.4 | 162/55 | No | 9.27 | 103 |
| TIA | 149 | 62 | <1 | 22.8 | Stopped | Yes (yes) | Yes | Treated | No | 34.3 | 143/87 | Yes | 4.41 | 65 |
| Stroke* | 16 | 42 | 3 | 2.4 | Yes | Yes (yes) | No | Unsuccessful treated | No | 19.6 | 95/62 | No | 4.08 | 66 |
| MI | 193 | 64 | 3 | 6.5 | Yes | Yes (no) | No | Yes, never treated | No | 19.9 | 122/86 | Yes | 2.93 | 80 |
| Stroke | 115 | 65 | 5 | 7.4 | No | No | No | Yes, never treated | No | 22.0 | 126/64 | Yes | 4.55 | 75 |
| MI | 146 | 66 | 10 | 9.8 | No | Yes (no) | No | Negative | No | 24.3 | 163/98 | No | 6.74 | 79 |
| IHD | 198 | 63 | 25 | 19.7 | Yes | Yes (yes) | No | Negative | No | 27.8 | 166/107 | Yes | 4.26 | 70 |
| Event . | Time, wk . | Age, y . | Factor level, % . | QRISK, % . | Smoking . | CVD in family (aged <60 y) . | DM . | HCV . | HIV . | BMI, kg/m2 . | BP, mm Hg . | aHT . | Cholesterol ratio . | Creatinine, μmol/L . |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stroke | 98 | 77 | <1 | 10.8 | No | No | No | Spontaneous clearance | Yes | 17.7 | 146/86 | No | 3.36 | 62 |
| IHD | 49 | 47 | <1 | 6.3 | No | Yes (no) | Yes | Treated | Yes | 23.0 | 120/90 | Yes | 5.00 | 202 |
| Stroke | 188 | 58 | <1 | 13.8 | No | Yes (yes) | No | Negative | No | 25.4 | 162/55 | No | 9.27 | 103 |
| TIA | 149 | 62 | <1 | 22.8 | Stopped | Yes (yes) | Yes | Treated | No | 34.3 | 143/87 | Yes | 4.41 | 65 |
| Stroke* | 16 | 42 | 3 | 2.4 | Yes | Yes (yes) | No | Unsuccessful treated | No | 19.6 | 95/62 | No | 4.08 | 66 |
| MI | 193 | 64 | 3 | 6.5 | Yes | Yes (no) | No | Yes, never treated | No | 19.9 | 122/86 | Yes | 2.93 | 80 |
| Stroke | 115 | 65 | 5 | 7.4 | No | No | No | Yes, never treated | No | 22.0 | 126/64 | Yes | 4.55 | 75 |
| MI | 146 | 66 | 10 | 9.8 | No | Yes (no) | No | Negative | No | 24.3 | 163/98 | No | 6.74 | 79 |
| IHD | 198 | 63 | 25 | 19.7 | Yes | Yes (yes) | No | Negative | No | 27.8 | 166/107 | Yes | 4.26 | 70 |
Type of event (fatal event marked with *) included ischemic stroke, IHD, TIA, and MI. Time indicates timing after inclusion (weeks). Age is at the time of event. QRISK indicates 5 years’ QRISK2011 score. CVD in family indicates positive family history of CVD (aged <60 years [premature CVD]). Creatinine indicates level at inclusion.
aHT, antihypertensive medication; BP, blood pressure at inclusion; Cholesterol ratio, total cholesterol/high-density lipoprotein cholesterol ratio; DM, diabetes mellitus; HCV, hepatitis C virus; IHD, ischemic heart disease; MI, myocardial infarction; TIA, transient ischemic attack.